AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines.

MLA

Cortese, Samuele, et al. “AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines.” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 63, no. 7, July 2024, pp. 663–65. EBSCOhost, https://doi.org/10.1016/j.jaac.2024.02.008.

APA

Cortese, S., Coghill, D., Mattingly, G. W., Rohde, L. A., Thom, R. P., Wilens, T. E., Wong, I. C. K., & Faraone, S. V. (2024). AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines. Journal of the American Academy of Child and Adolescent Psychiatry, 63(7), 663–665. https://doi.org/10.1016/j.jaac.2024.02.008

Chicago

Cortese, Samuele, David Coghill, Gregory W Mattingly, Luis Augusto Rohde, Robyn P Thom, Timothy E Wilens, Ian C K Wong, and Stephen V Faraone. 2024. “AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines.” Journal of the American Academy of Child and Adolescent Psychiatry 63 (7): 663–65. doi:10.1016/j.jaac.2024.02.008.